Rhythm Pharmaceuticals to Report Third Quarter 2021 Financial Results on Tuesday, November 2, 2021

NEXT STORY
Kirkland Lake Gold Announces Filing of Amended and Restated Detour Lake Mine Technical Report
PREV STORY
VectivBio Announces Successful Opening of US IND for Apraglutide for Acute Graft-Versus-Host Disease
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Bolt Biotherapeutics Announces Clinical Collaboration with Bristol Myers Squibb to Study BDC-1001 in Combination with Opdivo® for Treatment of HER2-Expressing Solid Tumors

author_avatar
NASDAQ Market News

American Health Council Recognizes Todd Heaton, MD, MPH as “America’s Best Doctor”

NEW YORK, Nov. 15, 2017 (GLOBE NEWSWIRE) -- The American Health Council is proud ...

author_avatar
NASDAQ Market News

Surface Oncology Announces New Randomized Phase 2 Clinical Study Evaluating SRF388 in Patients with First-Line Hepatocellular Carcinoma in Clinical Collaboration with Roche

author_avatar
NASDAQ Market News